The Plenary of the Competition Council decided to discontinue the examination of the case concerning the participation of the National Agency for Public Health (ANSP) in public procurement procedures for medical and healthcare services during the period 2019–2024. Following the investigation, there was insufficient evidence to establish an infringement of the Competition Law by ANSP, the Ministry of Health, or the contracting authorities concerned.
The investigation nevertheless revealed certain ambiguities in the regulatory framework governing the distinction between public health services and medical and healthcare services, as well as the conditions under which ANSP may provide such services. In particular, the provisions of Government Decision No. 533/2011 and Government Decision No. 1020/2011 need to be aligned in order to ensure their consistent application.
The Competition Council also drew attention to the fact that ANSP participates as a bidder in a competitive market while, at the same time, exercising authorisation and control powers over service providers operating in the same market. This dual role highlights the need for a clear separation of ANSP’s functions, so that all participants in public procurement procedures can benefit from equal and non-discriminatory conditions.
By its Decision of 29 July 2026, the Plenary of the Competition Council recommended that the Ministry of Health take measures to ensure the effective functional and economic separation of these activities. It also recommended clarifying in the legislation the categories of public health services that may be provided by ANSP and aligning the names and classifications of services, so that their nature and scope are clearly defined.
These recommendations aim to enhance the clarity of the regulatory framework and ensure fair conditions of competition in public procurement procedures.

